A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced Cancer
Clinical trial NCT03808870 · COMPLETED
Trial details
- NCT number
- NCT03808870
- Sponsor
- NatureWise Biotech & Medicals Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-28
- Primary completion
- 2022-02-12
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.